Last reviewed · How we verify
NCT05150873: ReSTHoNe
Anatomical Feasibility of an Off-the-shelf Scalloped Stent-graft for Infrarenal Abdominal Aneurysm With a Hostile Neck
trial testing CTA evaluation in Aortic Aneurysm in 1,000 participants. Completed in 1 December 2022.
1 June 2022
Quick facts
| Lead sponsor | Azienda Ospedaliero-Universitaria di Modena |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 1 January 2022 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 December 2022 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- CTA evaluation
Conditions studied
- Aortic Aneurysm — all drugs for Aortic Aneurysm →
Sponsor
Azienda Ospedaliero-Universitaria di Modena — full company profile →
Who can join
18 and older, any sex, with Aortic Aneurysm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In clinical practice a lot of EVAR cases are performed IFU for adverse neck anatomy(6) with acceptable short- and mid-term outcomes, but the long-term durability is currently an issue (7). Neck length shorter than 15 mm and angulation are two of. neck charteristics. that contribute more to define an "hostile neck" (8). The issue linked to the anatomical not feasibility of standard EVAR in patients not eligible for OR can be solved with custom made devices (CMD), but they were limited by high production costs and long time for creations (10-12 weeks)1. Nowadays no one off-the-shelf device aimed to overcome neck hostility in AAA is available on the market. The present study aims at evaluating the anatomical applicability of an off-the-shelf scalloped stent-graft to treat infrarenal AAA with a short and/or angulated neck.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Anatomical Feasibility of an Off-the-shelf Single-Renal Scalloped Stent-Graft for Hostile Neck Abdominal Aortic Aneurysm: A Preclinical Study.
Gennai S, Leone N, Andreoli F, Migliari M, et al · · 2025 · PMID 37096777 · DOI 10.1177/15266028231169164
Verify or expand the search:
- PubMed search for NCT05150873
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aortic Aneurysm
Currently open trials in the same condition.
- NCT07438327 — AI-CARE: Artificial Intelligence for Cardiovascular Analysis and Risk Evaluation · recruiting
- NCT06998498 — Prehabilitation for Aortic Aneurysm Surgery: Proof-of-concept Trial · NA · recruiting
- NCT06549348 — Radiation Free Study · NA · recruiting
- NCT06834607 — Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms · NA · recruiting
- NCT06762561 — Prophylactic Mesh Reinforcement After Open Aortic Aneurysm Repair · recruiting
Other Azienda Ospedaliero-Universitaria di Modena trials
Trials by the same sponsor.
- NCT06913530 — European Multicentre Study of Long-term Results Following Visceral Arteries Revascularization: the E-VisAR Study · not yet recruiting
- NCT06883890 — Extended LH Administration · Phase 2 · not yet recruiting
- NCT07245537 — ENDOGYM: A Holistic Approach With Pelvic Floor Physiotherapy and Yoga for Endometriosis Pain Relief · completed
- NCT05922202 — Influence of Frailty on Cardiovascular Events and Mortality in Patients With COPD. · recruiting
- NCT06236568 — Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05150873 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero-Universitaria di Modena
- Last refreshed: 6 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05150873.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing